Xiangyu Medical Co.,Ltd (SHA:688626)

Xiangyu Medical Co.,Ltd Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	784.47	743.18	663.78	726.31	829.62	487.24
Trading Asset Securities	50.18	-	162.19	636.47	648.14	-
Cash & Short-Term Investments	834.65	743.18	825.98	1,363	1,478	487.24
Cash Growth	14.02%	-10.02%	-39.39%	-7.78%	203.29%	33.75%
Accounts Receivable	77.55	67.7	57.99	34.35	43.03	32.74
Other Receivables	13.2	15.24	7.42	5	4.37	2.6
Receivables	90.76	82.95	65.41	39.35	47.4	35.34
Inventory	280.33	238.21	241.37	222.82	159.4	130.14
Prepaid Expenses	-	-	-	-	1.78	0.88
Other Current Assets	100.43	77.38	61.6	43.42	30.18	17.78
Total Current Assets	1,306	1,142	1,194	1,668	1,717	671.39
Property, Plant & Equipment	1,354	1,216	834.36	407.96	170.9	105.21
Long-Term Investments	24.92	266.03	258.52	17.09	16.71	2.55
Other Intangible Assets	211.03	216.89	207.7	204.25	208.78	51.62
Long-Term Accounts Receivable	25	33.53	47.79	43.03	50.2	29.88
Long-Term Deferred Tax Assets	10.17	9.55	11.22	14.7	11.4	9.12
Long-Term Deferred Charges	35.69	16.57	5.72	1.51	1.47	0.48
Other Long-Term Assets	304.88	27.14	32.47	11.15	6.57	111.28
Total Assets	3,272	2,928	2,592	2,368	2,183	981.53
Accounts Payable	142.7	135.62	109.69	103.87	27.71	14.92
Accrued Expenses	26.14	60.56	62.61	45.46	33.49	43.58
Short-Term Debt	582.75	354.1	27.02	17.15	-	50
Current Portion of Leases	1.21	1.12	-	-	-	-
Current Income Taxes Payable	9.11	1.45	5.06	2.01	8.71	11.05
Current Unearned Revenue	160.25	127.97	107.56	135.69	64.23	50.08
Other Current Liabilities	117.1	53.89	60.21	47.62	47.27	30.38
Total Current Liabilities	1,039	734.71	372.14	351.8	181.42	200.01
Long-Term Leases	9.85	11.14	8.44	-	-	-
Long-Term Unearned Revenue	136.29	127.25	104.11	65.1	53.72	37.16
Long-Term Deferred Tax Liabilities	-	-	-	11.31	1.83	1.08
Total Liabilities	1,231	873.1	484.69	428.22	236.97	238.25
Common Stock	160	160	160	160	160	120
Additional Paid-In Capital	1,306	1,299	1,294	1,294	1,294	285.39
Retained Earnings	763.04	756.04	735.7	546.36	480.83	338.13
Treasury Stock	-201.83	-176.5	-98.93	-73.27	-	-
Total Common Equity	2,027	2,039	2,091	1,928	1,935	743.52
Minority Interest	14.02	16.1	16.53	12.27	10.53	-0.23
Shareholders' Equity	2,041	2,055	2,107	1,940	1,946	743.29
Total Liabilities & Equity	3,272	2,928	2,592	2,368	2,183	981.53
Total Debt	639.86	366.35	35.46	17.15	-	50
Net Cash (Debt)	194.8	376.83	790.52	1,346	1,478	437.24
Net Cash Growth	-50.89%	-52.33%	-41.25%	-8.94%	237.97%	20.03%
Net Cash Per Share	1.28	2.42	5.01	8.47	9.88	3.65
Filing Date Shares Outstanding	156.07	154.19	157.11	157.73	160	160
Total Common Shares Outstanding	156.07	155.1	157.11	157.73	160	120
Working Capital	266.92	407	822.21	1,317	1,535	471.38
Book Value Per Share	12.99	13.14	13.31	12.22	12.09	6.20
Tangible Book Value	1,816	1,822	1,883	1,723	1,726	691.9
Tangible Book Value Per Share	11.63	11.75	11.99	10.93	10.79	5.77
Buildings	-	884.79	326.28	96.84	96.84	96.84
Machinery	-	173.84	146.98	61.96	52.32	45.79
Construction In Progress	-	252.27	428.83	314.09	77.09	8.4

Source: S&P Global Market Intelligence. Standard template. Financial Sources.